全文获取类型
收费全文 | 358篇 |
免费 | 24篇 |
专业分类
电工技术 | 3篇 |
化学工业 | 166篇 |
金属工艺 | 1篇 |
机械仪表 | 9篇 |
建筑科学 | 13篇 |
能源动力 | 6篇 |
轻工业 | 53篇 |
水利工程 | 2篇 |
石油天然气 | 1篇 |
无线电 | 13篇 |
一般工业技术 | 66篇 |
冶金工业 | 19篇 |
自动化技术 | 30篇 |
出版年
2024年 | 1篇 |
2023年 | 9篇 |
2022年 | 53篇 |
2021年 | 45篇 |
2020年 | 10篇 |
2019年 | 13篇 |
2018年 | 11篇 |
2017年 | 15篇 |
2016年 | 11篇 |
2015年 | 7篇 |
2014年 | 20篇 |
2013年 | 9篇 |
2012年 | 24篇 |
2011年 | 21篇 |
2010年 | 20篇 |
2009年 | 17篇 |
2008年 | 14篇 |
2007年 | 12篇 |
2006年 | 13篇 |
2005年 | 7篇 |
2004年 | 7篇 |
2003年 | 4篇 |
2002年 | 5篇 |
2001年 | 3篇 |
2000年 | 3篇 |
1999年 | 4篇 |
1998年 | 6篇 |
1997年 | 4篇 |
1996年 | 4篇 |
1995年 | 2篇 |
1994年 | 2篇 |
1991年 | 2篇 |
1989年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1980年 | 1篇 |
排序方式: 共有382条查询结果,搜索用时 15 毫秒
81.
Caterina Anania Giulia Brindisi Ivana Martinelli Edoardo Bonucci Miriam DOrsi Sara Ialongo Anna Nyffenegger Tonia Raso Mattia Spatuzzo Giovanna De Castro Anna Maria Zicari Carlo Carraro Maria Grazia Piccioni Francesca Olivero 《International journal of molecular sciences》2022,23(10)
Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by relapsing eczematous injuries and severe pruritus. In the last few years, the AD prevalence has been increasing, reaching 20% in children and 10% in adults in high-income countries. Recently, the potential role of probiotics in AD prevention has generated considerable interest. As many clinical studies show, the gut microbiota is able to modulate systemic inflammatory and immune responses influencing the development of sensitization and allergy. Probiotics are used increasingly against AD. However, the molecular mechanisms underlying the probiotics mediated anti-allergic effect remain unclear and there is controversy about their efficacy. In this narrative review, we examine the actual evidence on the effect of probiotic supplementation for AD prevention in the pediatric population, discussing also the potential biological mechanisms of action in this regard. 相似文献
82.
Caterina Allegretta Emanuele DAmico Virginia Manuti Carlo Avolio Massimo Conese 《International journal of molecular sciences》2022,23(7)
Autoimmune demyelinating diseases—including multiple sclerosis, neuromyelitis optica spectrum disorder, anti-myelin oligodendrocyte glycoprotein-associated disease, acute disseminated encephalomyelitis, and glial fibrillary acidic protein (GFAP)-associated meningoencephalomyelitis—are a heterogeneous group of diseases even though their common pathology is characterized by neuroinflammation, loss of myelin, and reactive astrogliosis. The lack of safe pharmacological therapies has purported the notion that cell-based treatments could be introduced to cure these patients. Among stem cells, mesenchymal stem cells (MSCs), obtained from various sources, are considered to be the ones with more interesting features in the context of demyelinating disorders, given that their secretome is fully equipped with an array of anti-inflammatory and neuroprotective molecules, such as mRNAs, miRNAs, lipids, and proteins with multiple functions. In this review, we discuss the potential of cell-free therapeutics utilizing MSC secretome-derived extracellular vesicles—and in particular exosomes—in the treatment of autoimmune demyelinating diseases, and provide an outlook for studies of their future applications. 相似文献
83.
Qihui Yang Don M. Gruenbacher Caterina M. Scoglio 《Journal of the Royal Society Interface》2022,19(188)
After one pandemic year of remote or hybrid instructional modes, universities struggled with plans for an in-person autumn (fall) semester in 2021. To help inform university reopening policies, we collected survey data on social contact patterns and developed an agent-based model to simulate the spread of severe acute respiratory syndrome coronavirus 2 in university settings. Considering a reproduction number of R0 = 3 and 70% immunization effectiveness, we estimated that at least 80% of the university population immunized through natural infection or vaccination is needed for safe university reopening with relaxed non-pharmaceutical interventions (NPIs). By contrast, at least 60% of the university population immunized through natural infection or vaccination is needed for safe university reopening when NPIs are adopted. Nevertheless, attention needs to be paid to large-gathering events that could lead to infection size spikes. At an immunization coverage of 70%, continuing NPIs, such as wearing masks, could lead to a 78.39% reduction in the maximum cumulative infections and a 67.59% reduction in the median cumulative infections. However, even though this reduction is very beneficial, there is still a possibility of non-negligible size outbreaks because the maximum cumulative infection size is equal to 1.61% of the population, which is substantial. 相似文献
84.
Lidia Ciccone Eugenia Piragine Simone Brogi Caterina Camodeca Raffaele Fucci Vincenzo Calderone Susanna Nencetti Alma Martelli Elisabetta Orlandini 《International journal of molecular sciences》2022,23(23)
The sirtuin 1 (SIRT1) activator resveratrol has emerged as a promising candidate for the prevention of vascular oxidative stress, which is a trigger for endothelial dysfunction. However, its clinical use is limited by low oral bioavailability. In this work, we have applied a previously developed computational protocol to identify the most promising derivatives from our in-house chemical library of resveratrol derivatives. The most promising compounds in terms of SIRT1 activation and oral bioavailability, predicted in silico, were evaluated for their ability to activate the isolated SIRT1 enzyme. Then, we assessed the antioxidant effects of the most effective derivative, compound 3d, in human umbilical vein endothelial cells (HUVECs) injured with H2O2 100 µM. The SIRT1 activator 3d significantly preserved cell viability and prevented an intracellular reactive oxygen species increase in HUVECs exposed to the oxidative stimulus. Such effects were partially reduced in the presence of a sirtuin inhibitor, sirtinol, confirming the potential role of sirtuins in the activity of resveratrol and its derivatives. Although 3d appeared less effective than resveratrol in activating the isolated enzyme, the effects exhibited by both compounds in HUVECs were almost superimposable, suggesting a higher ability of 3d to cross cell membranes and activate the intracellular target SIRT1. 相似文献
85.
Tommaso Piccoli Valeria Blandino Laura Maniscalco Domenica Matranga Fabiola Graziano Fabrizio Guajana Luisa Agnello Bruna Lo Sasso Caterina Maria Gambino Rosaria Vincenza Giglio Vincenzo La Bella Marcello Ciaccio Tiziana Colletti 《International journal of molecular sciences》2022,23(18)
Recently, the synaptic proteins neurogranin (Ng) and α-synuclein (α-Syn) have attracted scientific interest as potential biomarkers for synaptic dysfunction in neurodegenerative diseases. In this study, we measured the CSF Ng and α-Syn concentrations in patients affected by AD (n = 69), non-AD neurodegenerative disorders (n-AD = 50) and non-degenerative disorders (n-ND, n = 98). The concentrations of CSF Ng and α-Syn were significantly higher in AD than in n-AD and n-ND. Moreover, the Aβ42/Ng and Aβ42/α-Syn ratios showed statistically significant differences between groups and discriminated AD patients from n-AD patients, better than Ng or α-Syn alone. Regression analyses showed an association of higher Ng concentrations with MMSE < 24, pathological Aβ 42/40 ratios, pTau, tTau and the ApoEε4 genotype. Aβ 42/Ng was associated with MMSE < 24, an AD-related FDG-PET pattern, the ApoEε4 genotype, pathological Aβ 42 levels and Aβ 42/40 ratios, pTau, and tTau. Moreover, APO-Eε4 carriers showed higher Ng concentrations than non-carriers. Our results support the idea that the Aβ 42/Ng ratio is a reliable index of synaptic dysfunction/degeneration able to discriminate AD from other neurological conditions. 相似文献
86.
Paola Piscopo Valeria Manzini Roberto Rivabene Alessio Crestini Loredana Le Pera Elisabetta Pizzi Caterina Veroni Giuseppina Talarico Martina Peconi Anna Elisa Castellano Carmelo DAlessio Giuseppe Bruno Massimo Corbo Nicola Vanacore Eleonora Lacorte 《International journal of molecular sciences》2022,23(21)
The most frequently used biomarkers to support the diagnosis of Alzheimer’s Disease (AD) are Aβ42, total-Tau, and phospho-tau protein levels in CSF. Moreover, magnetic resonance imaging is used to assess hippocampal atrophy, 18F-FDG PET to identify abnormal brain metabolism, and PET imaging for amyloid deposition. These tests are rather complex and invasive and not easily applicable to clinical practice. Circulating non-coding RNAs, which are inherently stable and easy to manage, have been reported as promising biomarkers for central nervous system conditions. Recently, circular RNAs (circRNAs) as a novel class of ncRNAs have gained attention. We carried out a pilot study on five participants with AD and five healthy controls (HC) investigating circRNAs by Arraystar Human Circular RNA Microarray V2.0. Among them, 26 circRNAs were differentially expressed (FC ≥ 1.5, p < 0.05) in participants with AD compared to HC. From a top 10 of differentially expressed circRNAs, a validation study was carried out on four up-regulated (hsa_circRNA_050263, hsa_circRNA_403959, hsa_circRNA_003022, hsa_circRNA_100837) and two down-regulated (hsa_circRNA_102049, hsa_circRNA_102619) circRNAs in a larger population. Moreover, five subjects with mild cognitive impairment (MCI) were investigated. The analysis confirmed the upregulation of hsa_circRNA_050263, hsa_circRNA_403959, and hsa_circRNA_003022 both in subjects with AD and in MCI compared to HCs. We also investigated all microRNAs potentially interacting with the studied circRNAs. The GO enrichment analysis shows they are involved in the development of the nervous system, and in the cellular response to nerve growth factor stimuli, protein phosphorylation, apoptotic processes, and inflammation pathways, all of which are processes related to the pathology of AD. 相似文献
87.
Alessio Vizzoca Gioia Lucarini Elisabetta Tognoni Selene Tognarelli Leonardo Ricotti Lisa Gherardini Gualtiero Pelosi Mario Pellegrino Arianna Menciassi Settimio Grimaldi Caterina Cinti 《International journal of molecular sciences》2022,23(17)
Over the past few decades, finding more efficient and selective administration routes has gained significant attention due to its crucial role in the bioavailability, absorption rate and pharmacokinetics of therapeutic substances. The pulmonary delivery of drugs has become an attractive target of scientific and biomedical interest in the health care research area, as the lung, thanks to its high permeability and large absorptive surface area and good blood supply, is capable of absorbing pharmaceuticals either for local deposition or for systemic delivery. Nevertheless, the pulmonary drug delivery is relatively complex, and strategies to mitigate the effects of mechanical, chemical and immunological barriers are required. Herein, engineered erythrocytes, the Erythro–Magneto–Hemagglutinin (HA)–virosomes (EMHVs), are used as a novel strategy for efficiently delivering drugs to the lungs. EMHV bio-based carriers exploit the physical properties of magnetic nanoparticles to achieve effective targeting after their intravenous injection thanks to an external magnetic field. In addition, the presence of hemagglutinin fusion proteins on EMHVs’ membrane allows the DDS to anchor and fuse with the target tissue and locally release the therapeutic compound. Our results on the biomechanical and biophysical properties of EMHVs, such as the membrane robustness and deformability and the high magnetic susceptibility, as well as their in vivo biodistribution, highlight that this bio-inspired DDS is a promising platform for the controlled and lung-targeting delivery of drugs, and represents a valuable alternative to inhalation therapy to fulfill unmet clinical needs. 相似文献
88.
Sugar‐Based Arylsulfonamide Carboxylates as Selective and Water‐Soluble Matrix Metalloproteinase‐12 Inhibitors
下载免费PDF全文
![点击此处可从《ChemMedChem》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Dr. Elisa Nuti Doretta Cuffaro Dr. Felicia D'Andrea Dr. Lea Rosalia Livia Tepshi Dr. Marina Fabbi Grazia Carbotti Dr. Silvano Ferrini Dr. Salvatore Santamaria Dr. Caterina Camodeca Dr. Lidia Ciccone Prof. Elisabetta Orlandini Susanna Nencetti Dr. Enrico A. Stura Dr. Vincent Dive Prof. Armando Rossello 《ChemMedChem》2016,11(15):1626-1637
Matrix metalloproteinase‐12 (MMP‐12) can be considered an attractive target to study selective inhibitors useful in the development of new therapies for lung and cardiovascular diseases. In this study, a new series of arylsulfonamide carboxylates, with increased hydrophilicity resulting from conjugation with a β‐N‐acetyl‐d ‐glucosamine moiety, were designed and synthesized as MMP‐12 selective inhibitors. Their inhibitory activity was evaluated on human MMPs by using the fluorimetric assay, and a crystallographic analysis was performed to characterize their binding mode. Among these glycoconjugates, a nanomolar MMP‐12 inhibitor with improved water solubility, compound 3 [(R)‐2‐(N‐(2‐(3‐(2‐acetamido‐2‐deoxy‐β‐d ‐glucopyranosyl)thioureido)ethyl)biphenyl‐4‐ylsulfonamido)‐3‐methylbutanoic acid], was identified. 相似文献
89.
Patrizia Buttol Roberto Buonamici Luciano Naldesi Caterina Rinaldi Alessandra Zamagni Paolo Masoni 《Clean Technologies and Environmental Policy》2012,14(2):211-221
Small and medium-sized enterprises (SMEs) represent a key vector to introduce and diffuse eco-innovation in the market, because of their relevance to both the environment and the European gross domestic product. As they are often focused on continuous and incremental innovation of their products, the optimization of product eco-innovation paths can be considered a central aspect of their business. All phases of this process (awareness building and training, analysis, product (re)design and communication/certification) need to be supported to overcome the existing barriers, which mainly consist of lack of experience inside SMEs and cost of information, data, and tools. Information and Communication Technologies can play a role to lower some of the barriers, but currently the numerous services and tools available cover only specific aspects of the whole process, and are often too complex for their direct use by SMEs. The multilingual web-based platform Ecosmes.net here presented aims to integrate user-friendly and free-of-charge services and tools to support all phases of the product eco-innovation process in SMEs. The approach behind mainly consists in developing tailored, simplified tools, and in carrying out ??homogeneous product group?? studies, as a basis for the production of pre-elaborated information and data to be used with the tools developed. Experience gained in 5?years of applications has confirmed that Ecosmes.net can facilitate the start-up of the product eco-innovation process, but has also shown that not all the potentialities have been fully exploited. Moreover, as the eco-innovation market is not developed enough to allow economic management of these kinds of online services, a public initiative is advocated to face this challenge and support a continuous upgrading. Modes and opportunities are proposed and discussed in the conclusion. 相似文献
90.